医学
糖尿病
财政部
成熟度(心理)
医疗保健
重症监护医学
自身免疫性糖尿病
2型糖尿病
家庭医学
1型糖尿病
经济增长
内分泌学
心理学
发展心理学
考古
经济
历史
作者
Guanghong Zhou,Min Tao,Qin Wang,Xingyu Chen,Jing Liu,Lili Zhang
出处
期刊:World Journal of Diabetes
[Baishideng Publishing Group Co (World Journal of Diabetes)]
日期:2023-07-15
卷期号:14 (7): 1137-1145
标识
DOI:10.4239/wjd.v14.i7.1137
摘要
The prevalence of diabetes mellitus is increasing in resource limited settings. Simultaneously, there has been an increase in the number of novel therapies for the management of diabetes mellitus. However, use of novel antidiabetic therapies is limited because of major market access challenges in resource limited settings. Niching products to those patients with the highest absolute risk for major adverse cardiovascular outcomes, and thus most likely to benefit from the therapy, are less likely to have negative budget impact for funders. To improve access, and reduce morbidity and mortality, requires alignment amongst key stakeholders including patient advocacy groups, health care professional councils, national departments of health, the pharmaceutical industry, treasury and finance departments.
科研通智能强力驱动
Strongly Powered by AbleSci AI